RE: Posters are outhttps://www.thallion.com/docs/publications/25.AACR09-Nadia-Web.pdf
4601 shuts down Raf-1 regardless of mutation in Raf. Broader cytoxic spectrum than expected.
https://www.thallion.com/docs/publications/26.AACR09-Batist-Web.pdf
That's why they choose to combine it with TKI's. 4601 shows evidence of shutting down P13K. It has been hypothesis that PI3K-AKT and RAS-MAPK shut down simultaneously would probably kill lots of cancer cells. Probably, a very effective mecanism to solve cancer.
Partnership and licensing deal type of poster. Same impact as KRAS finding last year.
https://www.thallion.com/docs/publications/27.AACR09-Hassina-Web.pdf
Simply amazing data. Probably has even more potent effect than 4601. That's why licensor is back to hunt TLN with bogus claims. Black mailing TLN, again.
These posters should make potential partners, bidders and competitiors think twice